蛋白质酶抑制会诱导核形态的微管体依赖性变化
Sourabh Sengupta1, Abdullah Bashar Sami1, Jesse C Gatlin1
1Department of Molecular Biology, University of Wyoming, Laramie, WY 82071, USA.
iScience
|January 15, 2025
概括
蛋白质酶抑制通过影响微管细胞,急剧改变了核的形状和稳定性. 增加的Tubulin GCP6蛋白积累驱动这些核变化,影响细胞完整性.
科学领域:
- 细胞生物学 细胞生物学
- 蛋白质稳定和核形态学
背景情况:
- 被破坏的蛋白质稳定和改变的核形态与癌症和神经退行等疾病有关.
- 了解将蛋白质稳定与核形态联系在一起的直接机制是具有挑战性的,因为它会混细胞过程.
研究的目的:
- 研究蛋白质稳定性破坏对核形态学的直接影响.
- 阐明蛋白酶体抑制诱导的核变化背后的分子机制.
主要方法:
- 使用 *Xenopus* 蛋提取物系统来隔离无转录,转换或细胞循环进展的蛋白质稳定性破坏的影响.
- 应用蛋白酶体抑制和蛋白质组分析.
- 研究了Tubulin GCP6 (玛-布林复合蛋白6) 和微管体动态的作用.
- 在HeLa细胞中证实了这一发现.
主要成果:
- 蛋白质酶抑制诱导了核形态和稳定的快速,微管体依赖的变化.
- 微管的动力学和组织在蛋白质酶抑制后发生了改变.
- 蛋白质组分析显示,微管核子核子TubGCP6.6的丰度增加.
- TubGCP6的耗尽部分恢复了正常的核形态.
结论:
- TubGCP6的积累改变了核附近的微管子动态.
- 改变的微管力学会产生使核变形的力量,影响其形态和完整性.
- 这提供了蛋白质稳定和核结构完整性之间的直接机械联系.
相关概念视频
The Proteasome
807
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
807
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
The Proteasome Structure
687
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
687


